Abstract
Chronic inflammatory demyelinating polyneuropathy (CIDP), characterized by progressive weakness and impaired sensory function, is a rare autoimmune inflammatory disorder of the peripheral nervous system. Population-level real-world evidence are limited; this study aimed to describe patient characteristics and evaluate the annual healthcare resource utilization (HCRU) among patients with CIDP in Sweden.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
